CorEvitas

#CorEvitas #Mergers and acquisitions #Real world data #Thermo Fisher Scientific

Thermo Fisher Scientific acquires real-world evidence provider

Thermo Fisher Scientific has completed its acquisition of CorEvitas, a provider of real-world evidence for approved medical treatments and therapies, for $912.5 million. Real-world evidence is a high growth market segment as pharmaceutical and biotechnology customers, as well as regulating bodies, are increasingly looking to monitor… Read More

#Business & Investment #News